CD274 and non-small cell lung carcinoma: In the case of NSCLC, programmed death 1 (PD-1) on the surface of malignant cells binds to PD ligand 1 (PD-L1), which is expressed on activated T cells and pro-B cells, to avoid killing by immune cells and thus preventing immune surveillance.